Zimbabwe: COVID-19 - WHO Welcomes Death Reducing Drug

19 June 2020

The World Health Organisation (WHO) has welcomed initial trial results that show dexamethasone, an anti-inflammatory medication reduces the risk of death of COVID-19 patients on ventilators and oxygen support.

The clinical trial of the drug, led by a team from Oxford University in the United Kingdom, showed that dexamethasone reduces the risk of death of patients on ventilators by a third, and by a fifth on those on oxygen.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.